TECH

BIO-TECHNE CORPORATION

TECH · CIK 842023 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$1.2B
20182025
Net Income$0.1B
20182025
Operating CF$0.3B
20182025
Free Cash Flow$0.3B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$1.2B$1.2B$1.1B$1.1B$0.9B$0.7B$0.7B—
Cost of Revenue$0.4B$0.4B$0.4B$0.3B$0.3B$0.1B$0.1B$0.1B
Gross Profit$0.8B$0.8B$0.8B$0.8B$0.6B$0.5B$0.5B$0.4B
R&D Expense————————
SG&A Expense$0.6B$0.5B$0.4B$0.4B$0.3B$0.3B$0.3B$0.2B
Operating Income$0.1B$0.2B$0.3B$0.3B$0.2B$0.2B$0.1B$0.1B
Net Income$0.1B$0.2B$0.3B$0.3B$0.1B$0.1B$0.0B$0.0B
EPS (Basic)$0.47$1.07$1.81$6.93$3.62$1.54$0.43$1.11
EPS (Diluted)$0.46$1.05$1.76$6.63$3.47$1.48$0.42$1.08

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$2.6B$2.7B$2.6B$2.3B$2.3B$2.0B$1.9B$1.6B
Current Assets$0.6B$0.6B$0.6B$0.6B$0.5B$0.5B$0.4B$0.4B
Cash & Equivalents$0.2B$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B
Total Liabilities————————
Current Liabilities$0.2B$0.2B$0.1B$0.2B$0.2B$0.1B$0.1B$0.1B
Stockholders' Equity—$2.1B$2.0B$1.7B$1.6B$1.4B$1.2B$1.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.3B$0.3B$0.3B$0.3B$0.4B$0.2B$0.2B$0.2B
Investing Cash Flow$-0.0B$-0.2B$-0.3B$-0.1B$-0.2B$0.0B$-0.3B$-0.0B
Capital Expenditures$0.0B$0.1B$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B
Financing Cash Flow$-0.3B$-0.1B$0.0B$-0.2B$-0.1B$-0.2B$0.1B$-0.1B
← Companies